Annovis Bio, Inc.ANVSEarnings & Financial Report

NYSE · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Annovis Bio, Inc. is a clinical-stage biotechnology company focused on developing novel therapies for neurodegenerative disorders including Alzheimer's disease and Parkinson's disease. It targets both neuronal and synaptic dysfunction, operates primarily in the U.S. biopharmaceutical market, and advances its therapeutic pipeline through clinical trials to address unmet medical needs for patients with chronic neurological conditions.